For reference: 4 mg · 0.5 mL · phosphate-buffered diluent.
I would rather understand the derivation than memorise the outcome.
Two people I asked gave two answers that differ by a factor of ten, which is suggestive.
Can someone show the working rather than just the answer?
4 ÷ 0.5 = 8 mg/mL. Concentration is vial content divided by diluent volume, so 4 mg of peptide in 0.5 mL of phosphate-buffered diluent gives 8 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.08 mg — 80 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe part that matters: this is not exotic. It is just the difference between doing it deliberately and doing it approximately.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
The caveat on all of this is that it assumes the vial contains what the label says.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
The distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
If the material arrived warm and it was lyophilised, test it and proceed on the result.
Check the barrel marking, not your memory of it.
Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.
Do the arithmetic twice, ideally with someone else doing it independently.
edited 2 Feb 2026 by lyoph_cake — removed a claim I could not source
More usefully, the dissolution time is a signal — if it is longer than expected, something went wrong in either the lyophilisation or the shipping.
Do not use the same needle to pierce the stopper and to administer.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
Worth saying: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.